Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Kelly Filchner, PhD, MSN, RN, OCN, CCRC

Advertisement

Articles by Kelly Filchner, PhD, MSN, RN, OCN, CCRC

medical terminology

Are You Speaking the Same Language When Discussing Biomarkers With Your Patients?

ByKelly Filchner, PhD, MSN, RN, OCN, CCRC
April 21st 2023

Oncology Nurses: Have You Read a Good Book Lately?

ByKelly Filchner, PhD, MSN, RN, OCN, CCRC
May 6th 2019

“In hindsight, I understood the science behind why the trials were being conducted, but probably did not appreciate their history.”

Advertisement

Latest Updated Articles

  • Oncology Nurses: Have You Read a Good Book Lately?
    Oncology Nurses: Have You Read a Good Book Lately?

    May 6th 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer

2

FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses

3

Addressing Financial Toxicity: Team-Based Workflows in Oncology Care

4

Managing Daraxonrasib: Key Takeaways and Efficacy Insights for Oncology Nurses

5

SBRT Reduces Bowel Toxicity in Localized Intermediate-Risk Prostate Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us